Dividend Arrowhead Pharmaceuticals, Inc.
Equities
ARWR
US04280A1007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.82 USD | +2.31% |
|
-1.08% | -3.87% |
| 02-09 | Arrowhead Pharmaceuticals, Inc.(NasdaqGS:ARWR) added to S&P 400 Health Care | CI |
| 02-09 | Arrowhead Pharmaceuticals, Inc.(NasdaqGS:ARWR) added to S&P 400 | CI |
EPS & Dividend: Arrowhead Pharmaceuticals, Inc.
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.36 | -1.67 | -1.92 | -5 | -0.01 | -3.457 | -4.196 | -3.333 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 62.43 | 33.05 | 26.87 | 19.37 | 34.49 | 63.82 | 63.82 | 63.82 |
| Nbr of stocks (in thousands) | 104,259 | 105,849 | 107,193 | 124,315 | 138,258 | 140,032 | - | - |
| Announcement Date | 22/11/21 | 28/11/22 | 29/11/23 | 26/11/24 | 25/11/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Arrowhead Pharmaceuticals, Inc.
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -18.46x | 16.62x | 17.96x | |
| 0.02% | 0.04% | 47.83x | 7.49x | 11.28x | |
| 1.7% | 1.53% | 17.58x | 4.22x | 6.38x | |
| -.--% | -.--% | -25.5x | 74.47x | 51.38x | |
| -.--% | -.--% | -26.07x | 1.2x | 4.34x | |
| -.--% | -.--% | 29.5x | 3.02x | 6.39x | |
| -.--% | -.--% | 16.15x | 3.1x | 3.76x | |
| -.--% | -.--% | -173.33x | 20.66x | 42.7x | |
| -.--% | -.--% | -318.07x | 10.9x | 25.02x | |
| -.--% | -.--% | -11.33x | - | 141.5x | |
| Average | 0.17% | 0.16% | -46.17x | 15.74x | 31.07x | |
| Weighted average by Cap. | 0.32% | 0.29% | -15.64x | 15.94x | 22.78x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition